The Smith & Nephew plc Board is recommending a Final Dividend of 23.1¢ per share (46.2¢ per ADS). Together with the Interim Dividend of 14.4¢ per share (28.8¢ per ADS), this will give a total distribution of 37.5¢ per share (75.0¢ per ADS), unchanged from 2020 and 2019. Subject to confirmation at their Annual General Meeting, the Final Dividend will be paid on 11 May 2022 to shareholders on the register at the close of business on 1 April 2022.
Other financial highlights include:
Revenue of $5,212 million (2020: $4,560 million), up 14.3% on a reported basis and 10.3% on an underlying basis
o Sports Medicine & ENT and Advanced Wound Management revenue above pre-COVID levels
Operating profit of $593 million (2020: $295 million), up 101%
Trading profit of $936 million (2020: $683 million) with trading profit margin of 18.0% (2020: 15.0%)
o 300bps margin uplift reflects improved trading impact and discretionary cost control offset by higher logistics costs
Cash generated from operations of $1,048 million (2020: $972 million) with trading cash flow of $828 million (2020: $690 million)
EPS up 17% to 59.8¢, EPSA up 25% to 80.9¢
